Clinical Trials in Austin

Showing 8801-8820 of 15,205 trials

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

NCT02318303

Study to evaluate the two different strengths and dose regimen of GSP 301 to be effective in treatment of seasonal allergic rhinitis.

Seasonal Allergic Rhinitis

Glenmark Pharmaceuticals Ltd. India1,111 participantsStarted Dec 2014

Austin, Texas, United States • Austin, Texas, United States • Austin, Texas, United States +7 more locations

TERMINATEDNA< 1 mile

Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port

NCT00790699

The purpose of this study is to determine whether injecting Symlin and insulin through a multiple injection port is safe and effective. This will be measured by HbA1c values taken at the beginning of the study and at the final visit. The secondary objective of the study is to measure patient satisfaction toward using the multiple injection port.

Type 1 DiabetesType 2 Diabetes

Texas Diabetes & Endocrinology, P.A.31 participantsStarted Aug 2009

Austin, Texas, United States

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port

Find Trials by Condition in Austin

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

One Week Aligner Evaluation

National Marrow Donor Program Long-Term Donor Follow-Up

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy

KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Evaluation of CRB in PROM Patients

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Sustainable HIV Risk Reduction Strategies for Probationers

A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

Evaluation Of One Silicone Hydrogel Contact Lens and Two Hydrogel Lenses in Daily Wear

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea

Extension Study of Ataluren (PTC124) in Cystic Fibrosis

Open-Label Study of OTO-201 for Treatment of AOMT